ERFANIAN HAMID (Chief Executive Officer) purchased 36.4% of their position (100K shares) of ENZO BIOCHEM INC on the open market
Open‑market purchase worth $197.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/28/2022ACC: 0001213900-22-075598
Officer· Chief Executive Officer
Since Nov 2021
+400K
Net shares
Net buyer
$197.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
400K acquired
Non-Derivative Transactions1
Common Stock, $0.01 Par Value
Direct
Shares
+100K
Price / share
$1.97
Trade value
$197K
% of position
36.4%
11/23/2022
274.60K→374.60K
Total
Net shares
+100K
Net value
$197K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value Direct | 11/23/2022 | P · Purchase | +100K | $1.97 | $197K | 36.4% | 274.60K | 374.60K |
| Total | +100K | $197K | ||||||
Derivative Transactions1
Stock Option (to acquire Common Stock)
Direct
Converts to
Common Stock
300K shares
Shares
+300K
Strike price
1.97
Held after
300K
Exercisable
—
11/23/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (to acquire Common Stock) Direct | Common Stock300K shares | 11/23/2022 | A · Award | +300K | 1.97 | — | 300K |
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)1
Stock Option (to acquire Common Stock)
DirectUnderlying security
Common Stock
Underlying shares
700K
Shares owned
700K
Exercise price
3.39
Expiration
—
Exercise window
—
Total
Underlying
700K
Owned
700K
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (to acquire Common Stock) Direct | Common Stock | 3.39 | — | — | 700K | 700K |
| Total | 700K | 700K | ||||